Dr. Siva Krishna Mannem, MD

Dr. Mannem practices at MultiCare Yakima Memorial Hospital in Yakima, Washington, part of MultiCare Health System.

Dr. Mannem's NPI, 1073822235, was assigned on October 5, 2010. Dr. Mannem holds Washington license MD60707157.

Dr. Mannem's primary practice is MultiCare Yakima Memorial Hospital, at 2811 Tieton Drive, Yakima, WA 98902 in Yakima County. The practice phone is (509) 575-8000.

Dr. Mannem's primary practice is MultiCare Yakima Memorial Hospital in Yakima, Washington, part of MultiCare Health System. Dr. Mannem is also affiliated with Froedtert Hospital. The medical group on file is MultiCare Yakima Memorial. Dmand AI also links Dr. Mannem to 2 more hospitals, 1 clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Mannem's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mannem practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mannem's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mannem is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Mannem's licenses on file in 4 states: Washington, Kentucky, Texas and Wisconsin.

CMS data shows 1,389 Medicare services from Dr. Mannem across 4 procedure codes in 2024, all of them office visits, for 342 Medicare patients. Medicare paid $112,980 for them. Every service was in an office.

CMS counts 342 Medicare patients who saw Dr. Mannem in 2024. The largest group is 75 to 84, with 163 patients. 68% of them have high blood pressure, and 59% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mannem's median patient age at 76, with 49% women.

In 2024, Dr. Mannem wrote 1,860 Medicare Part D claims for 213 patients. 69% of them were for generic drugs. CMS names the drug for 1,620 of them, across 44 drugs with 11 or more claims each, at $6,281,921 in total drug cost. In 2023, CMS named 1,611 claims across 42 drugs.

Dr. Mannem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mannem as offering telehealth.

Dmand AI links 2 papers to Dr. Mannem in 2014. 2014 was the busiest year, with 2. Dr. Mannem's most frequent co-authors are Bagi Rp Jana, MD, Avi Bart Markowitz, MD and Mary John Ninan, MD.

CMS Open Payments shows 102 general payments to Dr. Mannem from 28 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 74% of the total. Seagen Inc. paid the most, $13,843.